Instil Bio (TIL) Interest & Investment Income (2021 - 2026)
Instil Bio (TIL) posted quarterly Interest & Investment Income of $678000.0 for Q1 2026, down 42.3% year-over-year from $1.2 million in Q1 2025, and down 9.12% quarter-over-quarter from $746000.0 in Q4 2025.
Instil Bio (TIL) Interest & Investment Income (2021 - 2026) Analysis & Trends
Instil Bio's Interest & Investment Income history runs 6 years deep, the most recent figure standing at $678000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 42.3% year-over-year to $678000.0; the TTM figure through Mar 2026 stood at $3.4 million (down 44.9% YoY), while the FY2025 annual figure was $3.9 million, down 44.78% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $678000.0, down from $746000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $2.3 million in Q3 2023, with the low at $97000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $1.4 million (2024), against an average of $1.4 million.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income surged 5700.0% in 2022, then plunged 46.01% in 2025.
- Instil Bio's Interest & Investment Income stood at $1.8 million in 2022, then gained by 22.22% to $2.2 million in 2023, then tumbled by 38.41% to $1.4 million in 2024, then slumped by 44.82% to $746000.0 in 2025, then fell by 9.12% to $678000.0 in 2026.
- Business Quant data shows TIL's Interest & Investment Income at $678000.0 in Q1 2026, $746000.0 in Q4 2025, and $893000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - | 632,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 632,000.00 |
| Mar 31, 2026 | 678,000.00 |
| Dec 31, 2025 | 746,000.00 |
| Sep 30, 2025 | 893,000.00 |
| Jun 30, 2025 | 1.04 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.65 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Sep 30, 2023 | 2.31 Mn |
| Jun 30, 2023 | 2.29 Mn |
| Mar 31, 2023 | 2.07 Mn |
| Dec 31, 2022 | 1.80 Mn |
| Sep 30, 2022 | 1.28 Mn |
| Jun 30, 2022 | 486,000.00 |
| Mar 31, 2022 | 97,000.00 |
| Dec 31, 2021 | 35,000.00 |
| Sep 30, 2021 | 22,000.00 |